Results

Total Results: 686 records

Showing results for "applicable".

301. Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/wdxHdZ2U5ggjuNW-nwun8n
     October 01, 2009 - Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force Mark Helfand, MD, MPH; David I. Buckley, MD, M…

302. Archived: Evidence Summary: Child Maltreatment: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/child-maltreatment-primary-care-interventions-november-2018
     November 27, 2018 - Abbreviations: CPS, child protective services; ED, emergency department; KQ, key question; NA, not applicable

303. Evidence Summary: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
     July 18, 2023 - hypercholesterolemia; KQ, key question; LDL-C, low-density lipoprotein cholesterol; MD, mean difference; NA, not applicable … lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; MD, mean difference; NA, not applicable

304. Screening for Colorectal Cancer: A Targeted, Updated Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/UCajZVxQEKLCgs59HV7ddE
     November 01, 2008 - The 2 largest and most comparable and applicable studies were conducted by Pickhardt and colleagues ( … 2D � 2-dimensional; 3D � 3-dimensional; CRC � colorectal cancer; CT � computed tomography; NA � not applicable … community set- tings, is challenging because of the lack of an independent gold standard and very few applicable … Not applicable. … Estimates are not precise and are not clearly applicable to the community endoscopists.

305. Archived: Final Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary4/colorectal-cancer-screening-2008
     October 15, 2008 - studies also estimated colonoscopy sensitivity. 49 , 53 , 54 The 2 largest and most comparable and applicable … community settings, is challenging because of the lack of an independent gold standard and very few applicable … 2D = 2-dimensional; 3D = 3-dimensional; CRC = colorectal cancer; CT = computed tomography; NA = not applicable … Not applicable. … Estimates are not precise and are not clearly applicable to the community endoscopists.

306. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
     May 01, 2018 - review; however, we believe our overview represents and synthesizes both the highest quality and most applicable … Abbreviations: FHCRC = Fred Hutchinson Cancer Research Center; N/A = not applicable; MISCAN-PRO = MIcrosimulaton … Prostate-Specific Antigen Growth and Prostate Cancer Progression; LY = life year(s); L = liter(s); NA = not applicable … Microsimulaton Screening Analysis Prostate Cancer model; LY = life year(s); L = liter(s); NA = not applicable

307. Archived: Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
     June 15, 2016 - Intervention: 84 Control: 100 0.84 (0.73-0.96) Abbreviations: CRC, colorectal cancer; NA, not applicable … Abbreviations: CRC, colorectal cancer; FIT, fecal immunochemical test; Hb, hemoglobin; NA, not applicable … Limited studies with large number of endoscopists that were applicable to community practice.

308. Qd4Zm2Uk2Ldubpa9Yyfbrm (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qd4Zm2Uk2LDuBPa9yyFBRM
     January 01, 2014 - Also needed is longitu- dinal follow-up of screening studies applicable to the United States that will

309. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16813/prostate-cancer-models-overview/pdf
     May 01, 2018 - review; however, we believe our overview represents and synthesizes both the highest quality and most applicable … Abbreviations: FHCRC = Fred Hutchinson Cancer Research Center; N/A = not applicable; MISCAN-PRO = MIcrosimulaton … Prostate-Specific Antigen Growth and Prostate Cancer Progression; LY = life year(s); L = liter(s); NA = not applicable … Microsimulaton Screening Analysis Prostate Cancer model; LY = life year(s); L = liter(s); NA = not applicable

310. Archived: Evidence Summary: Screening for Breast Cancer: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-breast-cancer/breast-cancer-screening-january-2016
     January 11, 2016 - Second, we only included studies that were applicable to current practice in the United States in order … Cancer Surveillance Consortium; CBE = clinical breast examination; CrI = credible interval; NA = not applicable … 2 All-cause deaths: 12 vs. 12 Fair † HR = hazard ratio; MR = mortality ratio; NA = not applicable

311. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - of variation in study estimates due to heterogeneity; IGRA, interferon-gamma release assay; NA, not applicable … assay; IUAT, International Union Against Tuberculosis; LTBI, latent tuberculosis infection; NA, not applicable … Findings were reasonably precise; consistency was not applicable (single study).

312. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
     February 13, 2018 - of ovarian cancer mortality defined according to clinically relevant in- ternational standards are applicable … non-Hispanic participants Abbreviations: FDA, US Food and Drug Administration; HR, hazard ratio; NA, not applicable … The PLCO trial is potentially more applicable to a US set- ting than the UKCTOCS trial, given differences

313. Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/osteoporosis-screening
     January 14, 2025 - these estimates represent the lower bounds of efficacy, it is not entirely clear that the findings are applicable … Further, it is unclear whether data on FRAX from other countries is applicable to the US setting, given … Male Osteoporosis Screening Tool; MSCORE, Male Simple Calculated Osteoporosis Risk Estimation; NA, not applicable

314. Procedure Manual Section 1. Overview of U.S. Preventive Services Task Force Structure and Processes | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-1
     December 01, 2013 - Procedure Manual Section 1. Overview of U.S. Preventive Services Task Force Structure and Processes Share to Facebook Share to X Share to WhatsApp Share to Email Print Table of Contents 1.1 Purpose 1.2 Intended Audience 1.3 History of the USP…

315. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
     September 03, 2019 - used 1 Nonsystematic review 68 Background only 14 Used for contextual question only 34 Population not applicable … thrombosis; ER−, estrogen receptor–negative; ER+, estrogen receptor–positive; KQ, key question; NA, not applicable … receptor–positive; ER−, estrogen receptor–negative; KQ, key question; LCIS, lobular carcinoma in situ; NA, not applicable

316. Archived: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-obstructive-pulmonary-disease-screening-2016
     April 05, 2016 - heterogeneous international studies of screening with handheld peak flow meters that were not considered applicable

317. Evidence Summary: Nonpregnant Adolescents and Adults: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nonpregnant-adolescents-and-adults1/human-immunodeficiency-virus-hiv-infection-screening
     June 11, 2019 - Abbreviations: ART, antiretroviral therapy; IRR, incidence rate ratio; KQ, key question; NA, not applicable

318. Evidence Summary: Bladder Cancer in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/bladder-cancer-in-adults-screening
     October 15, 2010 - screening test; includes a moderate sample size (50-100 persons) and a medium spectrum of patients (i.e., applicable

319. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Non-Vascular outcomes on Aspirin collaboration will provide some of this essential information. 58 Large applicable … of Atherosclerosis With Aspirin for Diabetes; JPPP = Japanese Primary Prevention Project; NA = not applicable

320. Screening for Colorectal Cancer: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/n4sdjxShTApRE6UxvyYuzG
     November 01, 2008 - tient will be followed by a surveillance regimen and recom- mendations for screening are no longer applicable … or adenom atous polyps are follow ed by a surveillance regim en, and screening guidelines are not applicable